Cellular Biomedicine Group, Inc
@CellBioMedGroup
Followers
211
Following
15
Media
9
Statuses
148
CBMG develops proprietary cell therapies for the treatment of cancerous and autoimmune diseases.
USA
Joined November 2012
Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer: https://t.co/bMNujqGBJw
#CARTCR
0
1
1
Janssen announced a worldwide collaboration and license agreement with @CellBioMedGroup to develop next generation CAR-T therapies for the treatment of patients with B-cell malignancies: https://t.co/DiX6PPaHbR
#BloodCancer
0
1
8
Expanding the potential of promising NHL drug candidates; CBMG announces exclusive collaboration & license agreement with @JanssenGlobal for anti CD19 & CD20 Bi-Specific and anti CD20 CAR-Ts for Non-Hodgkin Lymphoma #nonHodgkin #lymphoma #immunotherapy
prnewswire.com
/PRNewswire/ -- Cellular Biomedicine Group Inc. (CBMG or the Company), a clinical-stage biopharmaceutical company focused on discovery and development of...
0
1
3
CBMG granted FDA Clearance of IND Application for Novel TIL Therapy C-TIL051 for treatment of NSCLC
prnewswire.com
/PRNewswire/ -- Cellular Biomedicine Group Inc. (CBMG or the "Company"), a biopharmaceutical company developing innovative cellular immunotherapies for the...
0
0
0
CBMG Receives FDA RMAT and Fast Track Designations for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma https://t.co/7FCfPvsKJa
0
0
0
CBMG Receives FDA Clearance of IND Application for CAR-T Cell Therapy for non-Hodgkin Lymphoma
prnewswire.com
/PRNewswire/ -- Cellular Biomedicine Group Inc. (CBMG or the "Company"), a biopharmaceutical company developing innovative cellular immunotherapies for the...
0
0
0
CBMG Announces Completion of Merger, common stock no longer trading on Nasdaq
0
0
0
Proxy Advisory Firms Glass Lewis & ISS Recommend $CBMG Stockholders Vote FOR Proposed Merger
0
0
0
$CBMG CAR T-Cell Therapy Data to be Presented at 2020 ASH Annual Meeting
0
0
0
CBMG Reports Q3 2020 Financial Results and Business Highlights
0
0
0
$CBMG Q2 2020 financial & business highlights
0
0
0
$CBMG in Definitive Merger Agreement, would result in Company going private
0
0
0
$CBMG R&D Showcase presentation today
0
0
0
Results from $CBMG annual stockholder meeting
0
0
0
$CBMG poster on TCRs targeting AFP-Positive Liver Cancer at @AACR Annual Meeting today
0
0
0
Notice of $CBMG 2020 Annual Meeting of Stockholders
0
0
0
CBMG Q1 earnings call scheduled for May 6
0
0
0